[Follow-up study of fetal cardiac birth defects after prenatal diagnosis and graded counseling]

J J Shen1, C C Pang1, L Q Yang2

  • 1Department of Maternal-Fetal Cardiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Insights

Accurate prenatal diagnosis and grading of fetal cardiac birth defects (CBD) improve outcomes. This integrated approach refines postnatal treatment strategies and guides delivery decisions for better fetal health.

Area of Science:

  • Cardiology
  • Prenatal Diagnosis
  • Medical Genetics

Background:

  • Cardiac birth defects (CBD) are a significant concern in prenatal care.
  • Accurate diagnosis and counseling are crucial for managing fetal cardiac conditions.

Purpose of the Study:

  • To evaluate an integrated model for prenatal diagnosis, grading, counseling, and follow-up of fetal cardiac birth defects (CBD).
  • To establish a grading system for fetal CBD based on prognosis and postnatal management.

Main Methods:

  • Retrospective analysis of fetal echocardiography data from January 2018 to December 2020.
  • Development and application of a 6-grade classification system (Ⅰ-Ⅵ) for fetal CBD.
  • Follow-up of pregnancy outcomes, including induced labor rates, live birth rates, and diagnostic accuracy.

Main Results:

  • A total of 1,941 cases of fetal CBD were analyzed, with grades II and III comprising 54.0%.
  • The prenatal diagnosis concordance rate with postnatal diagnosis was 96.5% for live births.
  • Improved prognosis (grades I-V) correlated with increased live birth rates and decreased induced labor rates (P<0.001).

Conclusions:

  • Prenatal diagnosis and graded counseling are vital components of an integrated management model for fetal CBD.
  • Fetal CBD grading refines postnatal treatment strategies, informs delivery decisions, and serves as an evaluation standard.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
73
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
48
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
42
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
42
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
31